These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 25746464)

  • 1. Synthesis of a Coumarin-Based PPARγ Fluorescence Probe for Competitive Binding Assay.
    Yoshikawa C; Ishida H; Ohashi N; Itoh T
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Nelumbinis folium targeting PPARγ for weight management: A molecular docking and molecular dynamics simulations study.
    Wong AR; Yang AWH; Gill H; Lenon GB; Hung A
    Comput Biol Med; 2023 Nov; 166():107495. PubMed ID: 37742414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cheminformatic Read-Across Approach Revealed Ultraviolet Filter Cinoxate as an Obesogenic Peroxisome Proliferator-Activated Receptor γ Agonist.
    An S; Park IG; Hwang SY; Gong J; Lee Y; Ahn S; Noh M
    Chem Res Toxicol; 2024 Aug; 37(8):1344-1355. PubMed ID: 39095321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistance.
    Chigurupati S; Dhanaraj SA; Balakumar P
    Eur J Pharmacol; 2015 May; 755():50-7. PubMed ID: 25748601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway.
    Xu X; Wang Y; Wei Z; Wei W; Zhao P; Tong B; Xia Y; Dai Y
    Cell Death Dis; 2017 Mar; 8(3):e2723. PubMed ID: 28358365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist.
    Miyachi H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure optimization of a new class of PPARγ antagonists.
    Hernandez-Olmos V; Knape T; Heering J; von Knethen A; Kilu W; Kaiser A; Wurglics M; Helmstädter M; Merk D; Schubert-Zsilavecz M; Parnham MJ; Steinhilber D; Proschak E
    Bioorg Med Chem; 2019 Nov; 27(21):115082. PubMed ID: 31548084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
    Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
    Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
    Chen Q; Chen J; Sun T; Shen J; Shen X; Jiang H
    Anal Biochem; 2004 Dec; 335(2):253-9. PubMed ID: 15556564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
    Ye F; Zhang ZS; Luo HB; Shen JH; Chen KX; Shen X; Jiang HL
    Chembiochem; 2006 Jan; 7(1):74-82. PubMed ID: 16317783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists.
    Knape T; Flesch D; Kuchler L; Sha LK; Giegerich AK; Labocha S; Ferreirós N; Schmid T; Wurglics M; Schubert-Zsilavecz M; Proschak E; Brüne B; Parnham MJ; von Knethen A
    Eur J Pharmacol; 2015 May; 755():16-26. PubMed ID: 25746464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Design and Synthesis of Peroxisome Proliferator-activated Receptor (PPAR) Gamma Antagonists Based on the Principle of Operation of Nuclear Receptor I].
    Ohashi M; Miyachi H
    Yakugaku Zasshi; 2017; 137(8):957-967. PubMed ID: 28768949
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.